ONL Therapeutics Closes $4.25 Million in Series A Funding

 In News

Ocular Surgery News

ONL Therapeutics has closed $4.25 million in Series A funding for preclinical development of its lead therapeutic candidate…

Leave a Comment

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search